A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction

Objectives The aim of this study was to test whether the left ventricular assist device (LVAD) Impella LP2.5 (Abiomed Europe GmbH, Aachen, Germany) provides superior hemodynamic support compared with the intra-aortic balloon pump (IABP). Background Cardiogenic shock caused by left ventricular failur...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2008-11, Vol.52 (19), p.1584-1588
Hauptverfasser:	Seyfarth, Melchior, MD, Sibbing, Dirk, MD, Bauer, Iris, MS, Fröhlich, Georg, MD, Bott-Flügel, Lorenz, MD, Byrne, Robert, MB, MRCPI, Dirschinger, Josef, MD, Kastrati, Adnan, MD, Schömig, Albert, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Cardiology Cardiology. Vascular system Cardiovascular Confidence Intervals Coronary heart disease Coronary vessels Critical Illness Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care Equipment Safety Feasibility Studies Female Heart Heart attacks heart-assist device Heart-Assist Devices hemodynamics Hemodynamics - physiology Humans Intensive care medicine Internal Medicine Intra-Aortic Balloon Pumping Male Medical sciences Middle Aged Mortality myocardial infarction Myocardial Infarction - complications Myocardial Infarction - diagnosis Myocarditis. Cardiomyopathies Probability Prognosis Prospective Studies Risk Assessment Sensitivity and Specificity shock Shock, Cardiogenic - etiology Shock, Cardiogenic - mortality Shock, Cardiogenic - surgery Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!